🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Amyloidosis, Primary

SMS-Based Remote Symptom Monitoring for Patients With Plasma Cell Disorders NCT07850284n/a1 site📍 Rochester Mayo Clinic · Tests: Non-Interventional Study A Phase II Study to Evaluate the Efficacy and Safety of Teclistamab in Combination With Daratumumab (Tec-Dara) in Newly Diagnosed Multiple Myeloma With Concurrent Light Chain Amyloidosis (MM+AL). NCT07638683Phase 21 site📍 Shanghai Shanghai Zhongshan Hospital · Tests: Teclistamab Prospective Study of Teclistamab in the Treatment of Systemic AL Amyloidosis NCT06699394NA2 sites📍 Beijing📍 Beijing Peking University People's Hospital · Tests: Teclistamab (Tec) Study of HBI0101 (NXC-201) CAR-T Therapy in Multiple Myeloma and Light-Chain Amyloidosis NCT06971380Phase 21 site📍 Jerusalem Polina Stepensky · Tests: HBI0101 CART Promoting Diagnosis and Management of AL in Italy (ProDigALIty) NCT06383143n/a4 sites📍 Bari📍 Catania📍 Pavia Fondazione IRCCS Policlinico San Matteo di Pavia · Tests: no intervention Essen Amyloidosis Registry NCT06887283n/a1 site📍 Essen University Hospital, Essen Collection of Samples and Clinical Data From Patients With Amyloid Diseases NCT00898235n/a1 site📍 Boston Boston Medical Center · Tests: clonality analysis, polymerase chain reaction, protein analysis, biologic sample preservation procedure, laboratory bio… Rapid dFLC Response Predict CHR in AL Amyloidosis NCT06627309n/a8 sites📍 Beijing📍 Beijing📍 Beijing Peking University People's Hospital · Tests: Dara IV, Bortezomib (drug), Dexamethasone, Cyclophosphamide (CTX), Dara SC Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone Therapy for Patients with MIDD NCT06418477Phase 23 sites📍 Beijing📍 Beijing📍 Guangzhou Peking University People's Hospital · Tests: Dara-CyBorD Screening for AL Amyloidosis in Smoldering Multiple Myeloma NCT06365060n/a13 sites📍 Birmingham📍 Los Angeles📍 San Francisco Tufts Medical Center Daratumumab for Patients With Light Chain Amyloidosis NCT06376214NA1 site📍 Nanjing Nanjing University School of Medicine · Tests: Dratumumab / Hyaluronidase Injection [Darzalex Faspro], Pomalidomide 4 MG, autologous stem cell transplantation (ASCT) Study Evaluating the Efficacy and Safety of CM336 Injection in the Treatment of Light-Chain Amyloidosis NCT07039578Phase 22 sites📍 Beijing📍 Tianjin Keymed Biosciences Co.Ltd · Tests: CM336 Injection(Low dose group), CM336 Injection(High dose group) A Registry of AL Amyloidosis (ReAL) NCT04839003n/a1 site📍 Pavia Fondazione IRCCS Policlinico San Matteo di Pavia Bortezomib, Pomalidomide, Dexamethasone for Systemic AL Amyloidosis NCT06342466Phase 21 site📍 Beijing Jin Lu, MD · Tests: Bortezomib, Pomalidomide, Dexamethasone A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis NCT05652335Phase 129 sites📍 Duarte📍 Irvine📍 San Francisco Janssen Research & Development, LLC · Tests: JNJ-79635322 The Swedish BioFINDER 2 Study NCT03174938NA2 sites📍 Ängelholm📍 Malmö Skane University Hospital · Tests: Flutemetamol F18 Injection, [18F]-RO6958948, Elecsys (Roche) Abeta42, Ttau and Ptau, Lumipulse (Fujirebio) Abeta42, Tta… The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas NCT07285044Phase 21 site📍 Jacksonville Mayo Clinic · Tests: Cancer Therapeutic Procedure, Cancer Therapeutic Procedure, Questionnaire Administration The Norwegian Immunotherapy in Multiple Myeloma Study NCT06855121n/a23 sites📍 Arendal📍 Ålesund📍 Bergen St. Olavs Hospital · Tests: Teclistamab, Elranatamab, Ciltacabtagene Autoleucel, Talquetamab, Idecabtagene vicleucel Study of GC012F, CAR-T Therapy Targeting CD19 and BCMA in Chinese Participants With Relapsed or Refractory AL Amyloidosis NCT07250269Phase 19 sites📍 Beijing📍 Beijing📍 Beijing Gracell Biotechnologies (Shanghai) Co., Ltd. · Tests: GC012F Injection Hungarian National Systemic Amyloidosis Registry NCT07689331n/a12 sites📍 Balatonfüred📍 Budapest📍 Budapest Semmelweis University A EUropean REgistry and Sample Sharing networK to Promote the Diagnosis and Management of Light Chain Amyloidosis (EUREKA) NCT06205953n/a6 sites📍 Heidelberg📍 Pavia📍 Utrecht Fondazione IRCCS Policlinico San Matteo di Pavia Evaluation of Skin Tests in Biotherapy Allergies NCT06971848NA1 site📍 Angers University Hospital, Angers · Tests: Drug skin tests (investigating hypersensitivity to a biotherapy) The Italian Transthyretin Amyloidosis Web-Network NCT05444920n/a30 sites📍 Legnano📍 Orbassano📍 Ancona Fondazione IRCCS Policlinico San Matteo di Pavia Investigating the Pathogenic Role of N-glycosylation in AL Amyloidosis: Molecular Bases, Diagnosis, and Treatment NCT07448779n/a1 site📍 Pavia Fondazione IRCCS Policlinico San Matteo di Pavia A Phase 1 Study of 99mTc-p5+14 in Healthy Volunteers and Patients With AL or ATTR Systemic Amyloidosis NCT05951816Phase 11 site📍 Knoxville University of Tennessee Graduate School of Medicine · Tests: 99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m., 99mTc-Pyrophosphate Molecular Imaging of Primary Amyloid Cardiomyopathy NCT02641145NA1 site📍 Boston Brigham and Women's Hospital · Tests: F-18 florbetapir/C-11 acetate PET, MRI, N-13 ammonia PET Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms Clinical Research NCT07085559EARLY Phase 11 site📍 Hefei Anhui Provincial Hospital · Tests: Metabolically Armed BCMA CAR-T cells. DapagliFLOzin in Renal AL Amyloidosis (FLORAL) NCT06420167Phase 21 site📍 Detroit Barbara Ann Karmanos Cancer Institute · Tests: Dapagliflozin Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis NCT06022939Phase 3117 sites📍 Goodyear📍 Tucson📍 Tucson SWOG Cancer Research Network · Tests: Autologous Hematopoietic Stem Cell Transplantation, Biopsy, Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow… Sonrotoclax Plus Dexamethasone With or Without Daratumumab Regimen in Patients With t(11;14) Primary AL Amyloidosis NCT07335887Phase 23 sites📍 Beijing📍 Beijing📍 Xi'an Peking University People's Hospital · Tests: sonrotoclax, Daratumumab, Dexamethasone
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy